CORE Diagnostics, a high-end diagnostics service provider, has announced raising $12 million from Eight Roads Ventures, US-based F-Prime Capital Partners and existing investor Artiman Ventures. Zoya ...

Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers. No financial terms were disclosed. Canopy Biosciences is backed by ...

Mumbai: Metropolis Healthcare Limited, a pathology laboratory chain, has announced its approval to acquire Delhi NCR-based Core Diagnostics. Led by Ameera Shah, this acquisition aims to strengthen ...

Metropolis Healthcare Limited, a pathology laboratory chain, has announced the acquisition of Delhi NCR-based Core Diagnostics, a company specialising in advanced cancer testing for Rs 246.8 crores.

Core Diagnostics has received USD 12 million (around Rs 82 crore) funding from various investors including US-based F-Prime Capital Partners. Core Diagnostics has received USD 12 million (around Rs 82 ...

Abbott ABT, a global leader in healthcare solutions, recently achieved a significant milestone with the FDA approval of its cutting-edge Alinity h-series hematology system. This approval is poised to ...

Seamless reading experience. Save your favourite. Despite advances in AI and ML, there will always be some differences between human and technological execution. A technology driven bot or machine can ...

Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...

On Jan 18, we issued an updated research report on Quest Diagnostics, Inc. DGX. The stock carries a Zacks Rank #3 (Hold). We are optimistic about Quest Diagnostics’ consistent efforts to refocus on ...

ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for ...